2.94

0.00% 0.00

Inventiva Adr (IVA)

Overview News Price History Discussions Forecast

Inventiva Adr stock is traded at $2.94, with a volume of 19,202. It is up +0.00% in the last 24 hours and down -7.26% over the past month. Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Previous Close:

$2.94

Open:

$3.04

24h Volume:

19,202

Relative Volume:

2.15

Market Cap:

$153.94M

Revenue:

$16.82M

Net Income/Loss:

$-112.19M

P/E Ratio:

-1.3253

EPS:

-2.2183

Net Cash Flow:

$-91.84M

1W Performance:

+0.00%

1M Performance:

-7.26%

6M Performance:

+65.17%

1Y Performance:

-20.11%

1-Day Range:

$2.94

$3.0501

1-Week Range:

$2.70

$3.10

52-Week Range:

$1.53

$3.98

Inventiva Adr Stock (IVA) Company Profile

Name

Inventiva Adr

Sector

Healthcare (1165)

Industry

Biotechnology (681)

Phone

Address

Employee

123

Twitter

Next Earnings Date

2025-03-26

Latest SEC Filings

IVA's Discussions on Twitter

Compare IVA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IVA Inventiva Adr	2.94	153.94M	16.82M	-112.19M	-91.84M	-2.2183
VRTX Vertex Pharmaceuticals Inc	484.74	124.48B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	617.00	67.45B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	567.09	34.59B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	255.76	33.10B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	271.04	29.15B	3.81B	-644.79M	-669.77M	-6.24

Inventiva Adr Stock (IVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-21-25	Initiated	TD Cowen	Buy
Nov-12-24	Initiated	UBS	Neutral
Oct-27-23	Initiated	Canaccord Genuity	Buy
May-31-23	Initiated	ROTH MKM	Buy
May-19-23	Upgrade	Societe Generale	Sell → Buy
Mar-17-23	Initiated	Stifel	Buy
Nov-15-22	Downgrade	Societe Generale	Buy → Sell
Mar-08-21	Downgrade	Societe Generale	Buy → Sell
Aug-05-20	Initiated	ROTH Capital	Buy
Aug-04-20	Initiated	Guggenheim	Buy
Aug-04-20	Initiated	Stifel	Buy

View All

Inventiva Adr Stock (IVA) Latest News

Apr 01, 2025

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée - GlobeNewswire Inc.

Apr 01, 2025

Mar 28, 2025

Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks

Mar 28, 2025

Jan 30, 2025

Top 10 Best Indian Companies In Smart Grids Solutions 2025 - Inventiva

Jan 30, 2025

Oct 24, 2024

Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Oct 24, 2024

Oct 14, 2024